A rare gene change found in a boy with an optic nerve tumor
Original title: Novel Germline ELP1 Splice-Acceptor Variant in NF1-Negative Optic Pathway Glioma: Expanding the Clinical Spectrum Associated With ELP1 Variation.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This is a single report about one child's genes, not a treatment a patient can get.
The short version
Doctors found a rare inherited gene change in a boy who had a tumor on his optic nerve pathway.
What was studied. This is a report about one 7-year-old boy with an optic pathway glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary. He did not have NF1, the condition often linked to these tumors. Doctors read his genes using whole exome sequencing.
What they found. They found a new change in a gene called ELP1. Experts rated the change as likely to be harmful. The boy inherited it from his father. The father carries the same change but has no symptoms.
What this means, and what it doesn't
What it could mean: Some optic pathway gliomas may be linked to changes in the ELP1 gene, even when NF1 is not the cause. Gene testing may help some families understand why a tumor happened. It also shows a parent can carry the same change and stay healthy.
What it doesn't mean: This is one report about one child. It is not a treatment, and it is not a cure. It does not prove this gene change causes tumors in other people. It does not mean anyone who carries it will get a tumor. The boy's father carries it and has no symptoms. This is very early evidence and is far from changing everyday care.
Source: PubMed, July 23, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.